In a cell-based model of coagulation, the small-molecule thrombin and FXa inhibitors (NOACs) can affect coagulation at both the initiation phase and the propagation phase. During initiation, a small amount of thrombin is produced, which participates in many amplification loops. The propagation phase produces the large burst of thrombin that leads to stable clot formation.